Manouchehrinia A - Search Results

1

Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.

Beiki O, Frumento P, Bottai M, Manouchehrinia A, Hillert J. Beiki O, et al. Among authors: manouchehrinia a. JAMA Neurol. 2019 Jun 1;76(6):665-671. doi: 10.1001/jamaneurol.2019.0330. JAMA Neurol. 2019. PMID: 30882868 Free PMC article.

2

Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study.

Manouchehrinia A, Tench CR, Maxted J, Bibani RH, Britton J, Constantinescu CS. Manouchehrinia A, et al. Brain. 2013 Jul;136(Pt 7):2298-304. doi: 10.1093/brain/awt139. Epub 2013 Jun 11. Brain. 2013. PMID: 23757766 Free PMC article.

3

Tobacco smoking and excess mortality in multiple sclerosis: a cohort study.

Manouchehrinia A, Weston M, Tench CR, Britton J, Constantinescu CS. Manouchehrinia A, et al. J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1091-5. doi: 10.1136/jnnp-2013-307187. Epub 2014 Feb 25. J Neurol Neurosurg Psychiatry. 2014. PMID: 24569687 Free PMC article.

4

Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios.

Manouchehrinia A, Tanasescu R, Tench CR, Constantinescu CS. Manouchehrinia A, et al. J Neurol Neurosurg Psychiatry. 2016 Mar;87(3):324-31. doi: 10.1136/jnnp-2015-310361. Epub 2015 May 2. J Neurol Neurosurg Psychiatry. 2016. PMID: 25935887

5

Multiple sclerosis course and clinical outcomes in patients with comorbid asthma: a survey study.

Manouchehrinia A, Edwards LJ, Roshanisefat H, Tench CR, Constantinescu CS. Manouchehrinia A, et al. BMJ Open. 2015 May 20;5(5):e007806. doi: 10.1136/bmjopen-2015-007806. BMJ Open. 2015. PMID: 25995241 Free PMC article.

6

Effect of Smoking Cessation on Multiple Sclerosis Prognosis.

Ramanujam R, Hedström AK, Manouchehrinia A, Alfredsson L, Olsson T, Bottai M, Hillert J. Ramanujam R, et al. Among authors: manouchehrinia a. JAMA Neurol. 2015 Oct;72(10):1117-23. doi: 10.1001/jamaneurol.2015.1788. JAMA Neurol. 2015. PMID: 26348720

7

A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study.

Westerlind H, Stawiarz L, Fink K, Hillert J, Manouchehrinia A. Westerlind H, et al. Among authors: manouchehrinia a. Mult Scler. 2016 Jul;22(8):1071-9. doi: 10.1177/1352458516643394. Epub 2016 Apr 12. Mult Scler. 2016. PMID: 27072687

8

Re: Declines in the diagnosis of primary progressive MS-A critical change in phenotype or critical measurement error?

Westerlind H, Stawiarz L, Fink K, Hillert J, Manouchehrinia A. Westerlind H, et al. Among authors: manouchehrinia a. Mult Scler. 2017 Feb;23(2):305-307. doi: 10.1177/1352458516669863. Epub 2016 Sep 28. Mult Scler. 2017. PMID: 27650518 No abstract available.

9

Importance of early treatment initiation in the clinical course of multiple sclerosis.

Kavaliunas A, Manouchehrinia A, Stawiarz L, Ramanujam R, Agholme J, Hedström AK, Beiki O, Glaser A, Hillert J. Kavaliunas A, et al. Among authors: manouchehrinia a. Mult Scler. 2017 Aug;23(9):1233-1240. doi: 10.1177/1352458516675039. Epub 2016 Oct 17. Mult Scler. 2017. PMID: 27754943

10

Clinical course of multiple sclerosis: A nationwide cohort study.

Manouchehrinia A, Beiki O, Hillert J. Manouchehrinia A, et al. Mult Scler. 2017 Oct;23(11):1488-1495. doi: 10.1177/1352458516681197. Epub 2016 Dec 12. Mult Scler. 2017. PMID: 27956559

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters